Innovation isn’t helpful if we can’t afford it In response to Paul Pescatello’s opinion, (Connecticut price controls will stifle biopharma innovation), Connecticut residents desperately need the Governor’s bill, HB 6447, to limit out-of-control drug price hikes. The bill isn’t price control; it’s a small step that balances innovation with affordability. Jay Gironimi Anyone who says you can’t put a price on human life hasn’t been to the pharmacy. Drug prices are too high, and those prices are being set not by hopes of therapeutic innovation, but in deference to shareholder value. Pharmaceutical companies are not the only ones at fault here. As premiums and deductibles continue to rise, I don’t see any health insurers on the breadline. But simply because they don’t shoulder all the blame, doesn’t mean they don’t deserve some it.